Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Lei Zhou

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper

Papers 1

  1. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway. Co-author DOI 10.1111/jcmm.15676↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rongxian Cao · 1 shared paper, 2020 · strength 0.11
  2. Guosen Wang · 1 shared paper, 2020 · strength 0.11
  3. Qi Dong · 1 shared paper, 2020 · strength 0.11
  4. Weiwei Sheng · 1 shared paper, 2020 · strength 0.11
  5. Ming Dong · 1 shared paper, 2020 · strength 0.11
  6. Chao Jia · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.